Yesterday’s strong market triggered a technical indicator, a follow-through signal that tells us buyers are lurking. Of course, today’s big decline so far isn’t good to see, but nevertheless, this and other measures (awful sentiment, etc.) tell us there should be support on weakness.
Read More
The good news is that many cannabis companies have been releasing their second quarter reports and the results have been excellent.
Read More
The cannabis sector is still in correction mode ... looking for a bottom somewhere.
Read More
While long-term prospects for the cannabis industry remain excellent, the sector as a whole remains in correction mode today, with the big Canadian stocks under the greatest pressure—and no one knows where the bottom is, though history tells us it will come when last...
Read More
Bad News Bears
The stock market in general is quite healthy, with the major indexes at or near their highs, and all Cabot’s market timing indicators positive.
But the cannabis sector is still weak.
Part of this weakness stems from the fact that cannabis was the sector...
Read More
The broad market is in fine shape, with most major indexes at or near their highs and all Cabot’s market-timing indicators bullish.
Read More
The marijuana sector’s charts have been weak overall since the sector’s March top.
Read More
Cooling Off
They say a picture is worth a thousand words. This picture of the Marijuana Index tells a story that be summed up in fourteen.
From January through March, marijuana stocks were hot.
Since then, they’ve been cooling off.
The reasons for the strength were From...
Read More
Many of our stocks seem stuck in the mud—not bad, but not blasting off like some of the market’s leading stocks. Also, looking at the Marijuana Index, we see that it’s now come back down to where it was in mid-January.
Read More
The market has been up for six straight days, marijuana stocks look good, overall, and while we don’t quite have a buy signal from our intermediate-term trend-following indicator, we are very close. Today we are averaging up in three stocks.
Read More
The broad market has advanced nicely since mid-day Monday when news that the Fed might lower interest rates sparked a wave of buying. Long-term, the future is bright. But short-term, the portfolio is happy holding a cash level of 23%, deferring new buying.
Read More
Cannabis News
Fundamentally, the fastest-growing industry in America continues its rapid evolution. Some analysts now estimate that marijuana will be an $80 billion business in few years, while CBD sales will hit $16 billion by 2025.
It’s hard to know. But one big step comes tomorrow the...
Read More
The market’s larger, longer-term trend remains up, and the odds are that the market will be higher later this year. But short-term, the market remains in a correction, and marijuana stocks, as a whole, are not fighting the trend.
Read More
Investing in up markets is easy. From the December low until recently, the strong market provided a huge tailwind that sent marijuana stocks soaring—and had our portfolio, at the peak, up 57.2% year-to-date.
Read More
Overall, cannabis/marijuana stocks still look fine, even though the stocks were generally soft yesterday, so I’m not doing a full update, but there has been action, both good and bad, in a few stocks worth mentioning.
Read More
Analyzing Stocks
I didn’t go to business school; I was an English major. But the values learned in our household were firmly grounded in free market capitalism and investing. Sunday mornings, after going to church, we would stop at the local newsstand to buy and...
Read More
Looking at the revenues of the 14 companies in our Marijuana Portfolio, the average growth rate in the latest quarter, relative to the previous year, was 409%. The median, for you statistical fans, was 255%. This is one fast-growing sector!
Read More
The broad stock market remains healthy, with all indexes at or near highs, with the exception of small-cap stocks, which are lagging. A rising tide lifts all boats.
Read More
Today’s update is brief, but it does include a couple of important observations about the behavior of cannabis stocks in recent weeks, as well as updates on all the portfolio stocks.
Read More
CBD Stocks Soar
I take a dose of CBD twice a day. I think it works. I sleep better and have less discomfort in my finger joints—early signs of arthritis. But I’m not sure that it’s working, because there have been no major medical on...
Read More